Literature DB >> 36040566

Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?

Dixitha Anugula1, Rhanderson Cardoso2, Gowtham R Grandhi3, Ron Blankstein2, Khurram Nasir4,5, Mouaz Al-Mallah1, Dipan J Shah1, Miguel Cainzos-Achirica6,7.   

Abstract

PURPOSE OF REVIEW: The coronary artery calcium score is a guideline-endorsed aid for further risk stratification in the primary prevention of atherosclerotic cardiovascular disease. The non-contrast scan performed for detection of coronary artery calcium also gives an opportunity to visualize calcifications in the thoracic aorta and in the heart valves, at no additional cost or radiation exposure. The purpose of this review was to discuss the potential clinical value of measuring thoracic aortic calcification, aortic valve calcification, and mitral annulus calcification. RECENT
FINDINGS: After two decades of active research, all three calcifications have been extensively evaluated, across various cohorts. We discuss classic and recent studies, current knowledge gaps, and future directions in this space. The added value of these measurements has traditionally been considered modest at best, and they are not currently discussed in relevant primary prevention guidelines in North America and Europe. However, recent studies evaluating high thoracic calcification thresholds and younger populations have further enriched this space. Specifically, some studies suggest that detection of severe thoracic aortic calcification may be helpful in further risk assessment and that detection of aortic valve calcifications may have important prognostic implications in younger individuals. Although more research is needed, particularly in larger young-to-middle-aged cohorts, future guidelines might consider including these features as risk-enhancing factors.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Calcifications; Cardiovascular disease; Computed tomography; Imaging; Primary prevention; Risk assessment

Mesh:

Substances:

Year:  2022        PMID: 36040566     DOI: 10.1007/s11883-022-01051-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.967


  58 in total

1.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

2.  Role of coronary artery calcium score in the primary prevention of cardiovascular disease.

Authors:  Khurram Nasir; Miguel Cainzos-Achirica
Journal:  BMJ       Date:  2021-05-04

3.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

4.  Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.

Authors:  John W McEvoy; Seth S Martin; Zeina A Dardari; Michael D Miedema; Veit Sandfort; Joseph Yeboah; Matthew J Budoff; David C Goff; Bruce M Psaty; Wendy S Post; Khurram Nasir; Roger S Blumenthal; Michael J Blaha
Journal:  Circulation       Date:  2016-11-23       Impact factor: 29.690

Review 5.  Coronary Calcium Score and Cardiovascular Risk.

Authors:  Philip Greenland; Michael J Blaha; Matthew J Budoff; Raimund Erbel; Karol E Watson
Journal:  J Am Coll Cardiol       Date:  2018-07-24       Impact factor: 24.094

Review 6.  Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure.

Authors:  Raimund Erbel; Matthew Budoff
Journal:  Eur Heart J       Date:  2012-04-30       Impact factor: 29.983

7.  Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis.

Authors:  Michael D Miedema; Daniel A Duprez; Jeffrey R Misialek; Michael J Blaha; Khurram Nasir; Michael G Silverman; Ron Blankstein; Matthew J Budoff; Philip Greenland; Aaron R Folsom
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-06

Review 8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

9.  Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis).

Authors:  Miguel Cainzos-Achirica; Michael D Miedema; John W McEvoy; Mahmoud Al Rifai; Philip Greenland; Zeina Dardari; Matthew Budoff; Roger S Blumenthal; Joseph Yeboah; Daniel A Duprez; Martin Bødtker Mortensen; Omar Dzaye; Jonathan Hong; Khurram Nasir; Michael J Blaha
Journal:  Circulation       Date:  2020-04-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.